Gastrointestinal & Hepatobiliary Research

The Saint John’s Cancer Institute is a cancer research organization dedicated to the understanding and curing of cancer in order to eliminate patient suffering worldwide.

Many of the physicians and surgeons who are treating and caring for patients in the GI Oncology Program at Providence Saint John’s are also faculty, adjunct faculty and physicians in a fellowship program affiliated with the Saint John’s Cancer Institute.

Our research efforts have helped establish more accurate staging methods leading to better quality measures. Dr. Bilchik’s research and the team at the Saint John’s Cancer Institute, through funding by the National Institutes of Health (NIH), has helped identify those patients who are likely cured by surgery alone, thereby avoiding the unnecessary toxicity of chemotherapy.

Learn More About Our Current Trials     View All Clinical Trials

Current Translational Research and Medicine Highlights

  • Innovative approaches to the treatment of liver, pancreas and colorectal cancer
  • Ultrastaging of gastrointestinal malignancies
  • Immunoprofiling to improve staging accuracy in gastrointestinal cancers

Learn More About our Translational Research and Publications

  • Immunotherapy of gastrointestinal cancers
  • The role of the microbiome in the pathogenesis of gastrointestinal cancers
  • Improvements in quality and value based health care